Monday Jul 21
Viral therapy could boost limb-saving cancer treatment
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Genmab A/S announced today that its partner, Janssen Biotech, Inc. plans to start a new Phase III study of daratumumab in multiple myeloma.
Ligand Pharmaceuticals: Appendix
Despite a significant downward correction in the share price of Ligand Pharmaceuticals since the June 16,2014 publication of its original research report on LGND, Lemelson Capital Management has since continued to increase its short position in the company.